Here's the Top Under-the-Radar Telemedicine Stock to Buy Now
The COVID-19 pandemic has revolutionized the telehealth sector -- and its momentum is not going away, even as life returns to normal. According to market surveys, 76% of patients are now comfortable using telehealth, compared to less than 15% before the pandemic.
One provider that is breaking ground in the sector is Hims & Hers Health (NYSE: HIMS). Despite its market cap of just $2 billion, Hims & Hers has more power than investors might think.
Source Fool.com